SE335528B - - Google Patents
Info
- Publication number
- SE335528B SE335528B SE13291/68A SE1329168A SE335528B SE 335528 B SE335528 B SE 335528B SE 13291/68 A SE13291/68 A SE 13291/68A SE 1329168 A SE1329168 A SE 1329168A SE 335528 B SE335528 B SE 335528B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J3/00—Processes of utilising sub-atmospheric or super-atmospheric pressure to effect chemical or physical change of matter; Apparatus therefor
- B01J3/02—Feed or outlet devices therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Filling Or Emptying Of Bunkers, Hoppers, And Tanks (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1594563A CH484084A (de) | 1963-12-24 | 1963-12-24 | Verfahren zur Herstellung eines neuen östrogen hochwirksamen Steroids |
CH641464A CH437219A (de) | 1964-05-15 | 1964-05-15 | Zellenschleuse |
CH691464 | 1964-05-27 | ||
CH1565464 | 1964-12-03 | ||
CH1565364 | 1964-12-03 | ||
CH1565564 | 1964-12-03 | ||
CH1565664 | 1964-12-03 | ||
CH1589664 | 1964-12-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE335528B true SE335528B (xx) | 1971-06-01 |
Family
ID=27570366
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE13289/68A SE335337B (xx) | 1963-12-24 | 1964-12-22 | |
SE15536/64A SE324565B (xx) | 1963-12-24 | 1964-12-22 | |
SE15537/64A SE316769B (xx) | 1963-12-24 | 1964-12-22 | |
SE13291/68A SE335528B (xx) | 1963-12-24 | 1964-12-22 | |
SE15535/64A SE324564B (xx) | 1963-12-24 | 1964-12-22 | |
SE13290/68A SE335338B (xx) | 1963-12-24 | 1964-12-22 | |
SE15534/64A SE325026B (xx) | 1963-12-24 | 1964-12-22 |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE13289/68A SE335337B (xx) | 1963-12-24 | 1964-12-22 | |
SE15536/64A SE324565B (xx) | 1963-12-24 | 1964-12-22 | |
SE15537/64A SE316769B (xx) | 1963-12-24 | 1964-12-22 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE15535/64A SE324564B (xx) | 1963-12-24 | 1964-12-22 | |
SE13290/68A SE335338B (xx) | 1963-12-24 | 1964-12-22 | |
SE15534/64A SE325026B (xx) | 1963-12-24 | 1964-12-22 |
Country Status (8)
Country | Link |
---|---|
US (5) | US3318929A (xx) |
BR (4) | BR6465648D0 (xx) |
CH (1) | CH484084A (xx) |
DE (6) | DE1443681C3 (xx) |
FR (2) | FR6478M (xx) |
GB (5) | GB1087317A (xx) |
NL (7) | NL6415016A (xx) |
SE (7) | SE335337B (xx) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3507888A (en) * | 1966-08-30 | 1970-04-21 | Searle & Co | Process and intermediates for manufacture of 17-oxygenated estr-4-en-3-ones |
US3511860A (en) * | 1966-09-26 | 1970-05-12 | Syntex Corp | Synthesis of 19-nor and ring a aromatic steroids and intermediates therefor |
US3626062A (en) * | 1967-09-08 | 1971-12-07 | Upjohn Co | Composition comprising 7{60 -methyl estradiol 3,17-bistrimethyl silyl ethers |
US3627894A (en) * | 1967-09-08 | 1971-12-14 | Upjohn Co | Pharmaceutical compositions comprising 72-methyl estrone and methods for using same |
US3626061A (en) * | 1967-09-08 | 1971-12-07 | Upjohn Co | Compositions comprising 7{60 -methyl-17{60 -lkylated estradiols |
DD145919B1 (de) * | 1978-06-28 | 1982-06-30 | Kurt Ponsold | Verfahren zur herstellung von 14,1 -methylenderivaten der oestranreihe |
US5227375A (en) * | 1990-02-08 | 1993-07-13 | Endorecherche, Inc. | Aromatase inhibitors |
US6548491B2 (en) * | 1997-12-24 | 2003-04-15 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6503896B1 (en) | 1997-12-24 | 2003-01-07 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
US6054446A (en) * | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
PL356465A1 (en) * | 2002-10-04 | 2004-04-05 | ANPHARM Przedsiębiorstwo Farmaceutyczne S.A. | METHOD OF MANUFACTURE OF 17beta-HYDROXY-7alpha-METHYL-19-NOR-17alpha-PREGN-5(10)-ENE-20-YNE-3-ONE |
PE20050677A1 (es) * | 2003-12-22 | 2005-10-04 | Akzo Nobel Nv | Esteroides con perfil androgenico y progestagenico mixto |
US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
UY29185A1 (es) * | 2004-11-02 | 2006-05-31 | Schering Ag | Formas de dosificación oral sólidas que contienen una dosis baja de estradiol |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2225419A (en) * | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
US2584271A (en) * | 1948-06-19 | 1952-02-05 | Searle & Co | Steroid derivatives and method for producing the same |
GB723697A (en) * | 1952-06-17 | 1955-02-09 | Alberto Ercoli | Improvements in the preparation of 3:17-diols of the cyclopentanopolyhydrophenanthrene series |
-
0
- NL NL125071D patent/NL125071C/xx active
- NL NL125069D patent/NL125069C/xx active
-
1963
- 1963-12-24 CH CH1594563A patent/CH484084A/de not_active IP Right Cessation
-
1964
- 1964-12-16 DE DE1443681A patent/DE1443681C3/de not_active Expired
- 1964-12-17 DE DE1443682A patent/DE1443682C3/de not_active Expired
- 1964-12-19 DE DE1443684A patent/DE1443684C3/de not_active Expired
- 1964-12-19 DE DEC34698A patent/DE1244777B/de active Pending
- 1964-12-19 DE DE1443683A patent/DE1443683C3/de not_active Expired
- 1964-12-21 US US420186A patent/US3318929A/en not_active Expired - Lifetime
- 1964-12-21 US US420146A patent/US3318925A/en not_active Expired - Lifetime
- 1964-12-21 US US420185A patent/US3318928A/en not_active Expired - Lifetime
- 1964-12-21 US US420164A patent/US3318926A/en not_active Expired - Lifetime
- 1964-12-21 US US420147A patent/US3318927A/en not_active Expired - Lifetime
- 1964-12-22 SE SE13289/68A patent/SE335337B/xx unknown
- 1964-12-22 GB GB52077/64A patent/GB1087317A/en not_active Expired
- 1964-12-22 SE SE15536/64A patent/SE324565B/xx unknown
- 1964-12-22 SE SE15537/64A patent/SE316769B/xx unknown
- 1964-12-22 GB GB52078/64A patent/GB1087318A/en not_active Expired
- 1964-12-22 GB GB52076/64A patent/GB1087316A/en not_active Expired
- 1964-12-22 SE SE13291/68A patent/SE335528B/xx unknown
- 1964-12-22 GB GB52079/64A patent/GB1087319A/en not_active Expired
- 1964-12-22 GB GB52080/64A patent/GB1087320A/en not_active Expired
- 1964-12-22 SE SE15535/64A patent/SE324564B/xx unknown
- 1964-12-22 SE SE13290/68A patent/SE335338B/xx unknown
- 1964-12-22 SE SE15534/64A patent/SE325026B/xx unknown
- 1964-12-23 NL NL6415016A patent/NL6415016A/xx unknown
- 1964-12-23 NL NL6415018A patent/NL6415018A/xx unknown
- 1964-12-23 NL NL6415015A patent/NL6415015A/xx unknown
- 1964-12-23 NL NL6415019A patent/NL6415019A/xx unknown
- 1964-12-23 NL NL6415017A patent/NL6415017A/xx unknown
- 1964-12-24 BR BR165648/64A patent/BR6465648D0/pt unknown
- 1964-12-24 BR BR165650/64A patent/BR6465650D0/pt unknown
- 1964-12-24 BR BR165649/64A patent/BR6465649D0/pt unknown
- 1964-12-24 BR BR165651/64A patent/BR6465651D0/pt unknown
-
1965
- 1965-03-16 FR FR9360A patent/FR6478M/fr not_active Expired
- 1965-03-18 FR FR9724Q patent/FR6479M/fr not_active Expired
- 1965-04-10 DE DE19651442586 patent/DE1442586A1/de active Pending